Hong Kong Pharmaceuticals & Biotech Leverage Leaders

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$125.1b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

3SBio

Market Cap: HK$44.0b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Sino Biopharmaceutical

Market Cap: HK$100.0b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

WuXi Biologics (Cayman)

Market Cap: HK$214.2b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.

Simcere Pharmaceutical Group

Market Cap: HK$29.6b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

China Medical System Holdings

Market Cap: HK$28.4b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$55.7b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Innovent Biologics

Market Cap: HK$174.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Duality Biotherapeutics

Market Cap: HK$17.7b

A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others in China and internationally.

Hansoh Pharmaceutical Group

Market Cap: HK$191.5b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

CSPC Pharmaceutical Group

Market Cap: HK$107.6b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Fujian Haixi Pharmaceuticals

Market Cap: HK$15.7b

Engages in research and development, production, and sale of pharmaceutical products in China.

Genscript Biotech

Market Cap: HK$76.6b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

InSilico Medicine Cayman TopCo

Market Cap: HK$26.5b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

United Laboratories International Holdings

Market Cap: HK$17.4b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

WuXi XDC Cayman

Market Cap: HK$101.5b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Grand Pharmaceutical Group

Market Cap: HK$18.5b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.